The federal government is stuck with 63 million doses of hydroxychloroquine now that the US Food and Drug Administration has revoked permission for the drug to be distributed to treat coronavirus patients

The government started stockpiling donated hydroxychloroquine in late March, after President Trump touted it as “very encouraging” and “very powerful” and a “game-changer.”

But Monday, the FDA revoked its emergency use authorization to use the drug to treat Covid-19, saying there was “no reason to believe” the drug was effective against the virus, and that it increased the risk of side effects, including heart problems.

That leaves the Strategic National Stockpile with 63 million doses of hydroxychloroquine, plus another 2 million doses of chloroquine, a related drug donated by Bayer, according to Carol Danko, a spokesperson for the US Department of Health and Human Services.

Many public health experts point to all of this as an unfortunate chapter in the history of the pandemic thus far.

“Nationally, we put a great emphasis on one drug, hydroxychloroquine,” said David Holtgrave, the dean of the School of Public Health at the University at Albany, who co-authored a study of the drug as a treatment for coronavirus. “I worry that history will judge this as having over-invested in one treatment pathway as opposed to looking more broadly at a larger number of treatment candidates.”

Before the FDA revoked its authorization, the stockpile had already distributed 31 million doses. Novartis and Mylan donated doses of the drug to the stockpile.

“HHS is working with the companies that donated the product to determine the available options for the product that remains in the Strategic National Stockpile,” Danko wrote in a statement to CNN.

Hydroxychloroquine has been used for many years to treat diseases such as malaria, rheumatoid arthritis, lupus. After President Trump started touting hydroxychloroquine as a treatment for Covid-19, patients with those illnesses reported having trouble finding the drug.

Medical reference: CNNHealth